In the ongoing saga over Food and Drug Administration (FDA) regulation of lab-developed tests (LDTs), a group of physicians working in academic medical centers is urging the Office of Management and Budget (OMB) not to issue any guidance or rule that puts LDTs under FDA authority. The July 16 letter, signed by almost two dozen…

This content is for Paid Members only.
Login Register